Date of this Version
A Rebuttable Presumption Against Reregistration has been issued against endrin. It is my own opinion that: First endrin should be critically examined, use by use, with respect to effectiveness and alleged hazard to non-target animals, be they pets, domestic stock or wildlife; and secondly, that a careful and complete review be made of all economic benefits against the hazards identified in the earlier review. The notice which appeared in the Federal Register emphasized the occasional harmful aspects of use and failed to give much or any credence to benefits. Certainly there must be some value to the grower and financial reward to the manufacturer or the product would soon be taken off the market.